Figure 3.
Survival curves according to combinations of RDI and PMV in patients who received adjuvant S-1 chemotherapy. Overall survival curves (A) and recurrence-free survival curves (B). PMV, psoas muscle mass volume; RDI, relative dose intensity Group A, patients with both high RDI and high PMV; Group B, patients with high RDI or high PMV (but not both); Group C, patients with both low RDI and low PMV. PMV = psoas muscle mass volume, RDI = relative dose intensity.